Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis Volume 11, 2010 - Issue 1-2
Journal homepage
799
Views
121
CrossRef citations to date
0
Altmetric
Original Article

Impaired glucose tolerance in patients with amyotrophic lateral sclerosis

Pierre-Francois Pradat APHP, Hôpital de la Pitié-Salpêtrière, Fédération des Maladies du Système Nerveux, ParisCorrespondence[email protected]
,
Gaelle Bruneteau APHP, Hôpital de la Pitié-Salpêtrière, Fédération des Maladies du Système Nerveux, Paris
,
Paul H. Gordon APHP, Hôpital de la Pitié-Salpêtrière, Fédération des Maladies du Système Nerveux, Paris
,
Luc Dupuis INSERM U692, Faculté de Médecine, Strasbourg, Université de Strasbourg, Strasbourg
,
Dominique Bonnefont-Rousselot APHP, Hôpital de la Pitié-Salpêtrière, UF de Biochimie des Maladies Métaboliques, Paris and Université Paris Descartes, Faculté de Pharmacie, Département de Biochimie, Paris
,
Dominique Simon APHP, Hôpital de la Pitié-Salpêtrière, Service de Diabétologie, Paris and INSERM, U 780, Villejuif
,
Francois Salachas APHP, Hôpital de la Pitié-Salpêtrière, Fédération des Maladies du Système Nerveux, Paris
,
Philippe Corcia Hôpital Bretonneau, Service de Neurologie, Tours
,
Vincent Frochot APHP, Hôpital de la Pitié-Salpêtrière, Service de Biochimie Endocrinienne et Oncologique, Paris
,
Jean-Marc Lacorte APHP, Hôpital de la Pitié-Salpêtrière, Service de Biochimie Endocrinienne et Oncologique, Paris
,
Claude Jardel APHP, Hôpital de la Pitié-Salpêtrière, Service de Biochimie Métabolique,
,
Christiane Coussieu APHP, Hôpital de la Pitié-Salpêtrière, Service de Biochimie Endocrinienne et Oncologique, Paris
,
Nadine Le Forestier APHP, Hôpital de la Pitié-Salpêtrière, Fédération des Maladies du Système Nerveux, Paris
,
Lucette Lacomblez APHP, Hôpital de la Pitié-Salpêtrière, Fédération des Maladies du Système Nerveux, Paris; UPMC, Faculté de Médecine, Hôpital de la Pitié-Salpêtrière,; INSERM U678, Faculté de Médecine, Paris, France
,
Jean-Philippe Loeffler INSERM U692, Faculté de Médecine, Strasbourg, Université de Strasbourg, Strasbourg
&
Vincent Meininger APHP, Hôpital de la Pitié-Salpêtrière, Fédération des Maladies du Système Nerveux, Paris; UPMC, Faculté de Médecine, Hôpital de la Pitié-Salpêtrière,
 show all
Pages 166-171 | Received 02 Jan 2009, Accepted 15 Feb 2009, Published online: 26 Feb 2010

Citations (121)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Linjing Zhang, Lu Chen & Dongsheng Fan. (2020) The protective role of pre-morbid type 2 diabetes in patients with amyotrophic lateral sclerosis: a center-based survey in China. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 209-215.
Read now
Boeun Kim, Youri Jin, Seung Hyun Kim & Yongsoon Park. (2020) Association between macronutrient intake and amyotrophic lateral sclerosis prognosis. Nutritional Neuroscience 23:1, pages 8-15.
Read now
Shyuan T Ngo, Jia D Mi, Robert D Henderson, Pamela A McCombe & Frederik J Steyn. (2017) Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions. Degenerative Neurological and Neuromuscular Disease 7, pages 95-108.
Read now
Benjamin Gaastra, Aleksey Shatunov, Sara Pulit, Ashley R. Jones, William Sproviero, Alexandra Gillett, Zhongbo Chen, Janine Kirby, Isabella Fogh, John F. Powell, P. Nigel Leigh, Karen E. Morrison, Pamela J. Shaw, Christopher E. Shaw, Leonard H. van den Berg, Jan H. Veldink, Cathryn M. Lewis & Ammar Al-Chalabi. (2016) Rare genetic variation in UNC13A may modify survival in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:7-8, pages 593-599.
Read now
. (2013) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:sup2, pages 1-63.
Read now
. (2012) THEME 4 HUMAN CELL BIOLOGY AND PATHOLOGY. Amyotrophic Lateral Sclerosis 13:sup1, pages 99-110.
Read now
Svetlana I Kostic Dedic, Zorica Stevic, Velimir Dedic, Vidosava Rakocevic Stojanovic, Milena Milicev & Dragana Lavrnic. (2012) Is hyperlipidemia correlated with longer survival in patients with amyotrophic lateral sclerosis?. Neurological Research 34:6, pages 576-580.
Read now
Toshio Shimizu, Utako Nagaoka, Yuki Nakayama, Akihiro Kawata, Chiharu Kugimoto, Yoshiyuki Kuroiwa, Mitsuru Kawai, Takayoshi Shimohata, Masatoyo Nishizawa, Ban Mihara, Hajime Arahata, Naoki Fujii, Reiko Namba, Hiroaki Ito, Takashi Imai, Keigo Nobukuni, Kiyohiko Kondo, Mieko Ogino, Takashi Nakajima & Tetsuo Komori. (2012) Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: A multicenter study in Japan. Amyotrophic Lateral Sclerosis 13:4, pages 363-366.
Read now
Toshio Shimizu, Masayuki Honda, Takuya Ohashi, Motoyoshi Tsujino, Utako Nagaoka, Akihiro Kawata, Kazuhiko Watabe, Shiro Matsubara & Hideaki Hayashi. (2011) Hyperosmolar hyperglycemic state in advanced amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 12:5, pages 379-381.
Read now

Articles from other publishers (112)

Thibaut Burg & Ludo Van Den Bosch. (2023) Abnormal energy metabolism in ALS: a key player?. Current Opinion in Neurology 36:4, pages 338-345.
Crossref
Kanagavalli Ramasubbu & V. Devi Rajeswari. (2022) Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review. Molecular and Cellular Biochemistry 478:6, pages 1307-1324.
Crossref
Katarina Maksimovic, Mohieldin Youssef, Justin You, Hoon-Ki Sung & Jeehye Park. (2023) Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models. Biomolecules 13:5, pages 863.
Crossref
Peter W. Stacpoole & Charles E. McCall. (2023) The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat. Mitochondrion 70, pages 59-102.
Crossref
Johannes Dorst, Patrick Weydt, David Brenner, Simon Witzel, Katharina Kandler, André Huss, Christine Herrmann, Maximilian Wiesenfarth, Antje Knehr, Kornelia Günther, Kathrin Müller, Jochen H. Weishaupt, Johannes Prudlo, Karin Forsberg, Peter M. Andersen, Angela Rosenbohm, Joachim Schuster, Francesco Roselli, Luc Dupuis, Benjamin Mayer, Hayrettin Tumani, Jan Kassubek & Albert C. Ludolph. (2023) Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers. eBioMedicine 90, pages 104521.
Crossref
Kailin Xia, Simon Witzel, Christina Witzel, Veronika Klose, Dongsheng Fan, Albert C. Ludolph & Johannes Dorst. (2022) Mutation‐specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis. European Journal of Neurology 30:1, pages 87-95.
Crossref
Audrey Labarre, Ericka Guitard, Gilles Tossing, Anik Forest, Eric Bareke, Marjorie Labrecque, Martine Tétreault, Matthieu Ruiz & J. Alex Parker. (2022) Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration. Communications Biology 5:1.
Crossref
Carmen Marino, Manuela Grimaldi, Eduardo Maria Sommella, Tania Ciaglia, Angelo Santoro, Michela Buonocore, Emanuela Salviati, Francesca Trojsi, Arianna Polverino, Pierpaolo Sorrentino, Giuseppe Sorrentino, Pietro Campiglia & Anna Maria D’Ursi. (2022) The Metabolomic Profile in Amyotrophic Lateral Sclerosis Changes According to the Progression of the Disease: An Exploratory Study. Metabolites 12:9, pages 837.
Crossref
Andrew T. Nelson & Davide Trotti. (2022) Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis. Neurotherapeutics 19:4, pages 1102-1118.
Crossref
Sigal Ben-Zaken, Beatrice Nefussy, Yoav Meckel, Alon Eliakim, Dan Nemet, Marc Gotkine, Dana Lorber, Aviva Zeev & Vivian E. Drory. (2022) Common genetic basis of ALS patients and soccer players may contribute to disease risk. Neurological Sciences 43:7, pages 4231-4238.
Crossref
Jin‐Yue Li, Li‐Ying Cui, Xiao‐Han Sun, Dong‐chao Shen, Xun‐Zhe Yang, Qing Liu & Ming‐Sheng Liu. (2022) Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 9:7, pages 1027-1038.
Crossref
Juan Miguel Godoy-Corchuelo, Luis C. Fernández-Beltrán, Zeinab Ali, María J. Gil-Moreno, Juan I. López-Carbonero, Antonio Guerrero-Sola, Angélica Larrad-Sainz, Jorge Matias-Guiu, Jordi A. Matias-Guiu, Thomas J. Cunningham & Silvia Corrochano. (2022) Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders. Biomedicines 10:5, pages 1105.
Crossref
Kelby M. Killoy, Benjamin A. Harlan, Mariana Pehar & Marcelo R. Vargas. (2022) NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons. The FASEB Journal 36:4.
Crossref
Jon Ondaro, Haizea Hernandez-Eguiazu, Maddi Garciandia-Arcelus, Raúl Loera-Valencia, Laura Rodriguez-Gómez, Andrés Jiménez-Zúñiga, Julen Goikolea, Patricia Rodriguez-Rodriguez, Javier Ruiz-Martinez, Fermín Moreno, Adolfo Lopez de Munain, Ian James Holt, Francisco Javier Gil-Bea & Gorka Gereñu. (2022) Defects of Nutrient Signaling and Autophagy in Neurodegeneration. Frontiers in Cell and Developmental Biology 10.
Crossref
Jun Kaneko, Ryu-ichiro Sato, Masahide Watanabe, Kiyomitsu Oyanagi & Michiaki Kinoshita. (2022) An autopsy case report of a patient with frontotemporal dementia with motor neuron disease in totally locked-in state showing hyperosmolar hyperosmotic state高浸透圧高血糖状態を2回発症しtotally locked-in state（TLS）を呈した運動ニューロン病を伴う前頭側頭型認知症の剖検例. Rinsho Shinkeigaku 62:8, pages 595-601.
Crossref
Titaya Lerskiatiphanich, Jianina Marallag & JohnD Lee. (2022) Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet. Neural Regeneration Research 17:9, pages 1975.
Crossref
Cory J. Holdom, Frederik J. Steyn, Robert D. Henderson, Pamela A. McCombe, Mary-Louise Rogers & Shyuan T. Ngo. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers 263 306 .
Simon J. Guillot, Matei Bolborea & Luc Dupuis. (2021) Dysregulation of energy homeostasis in amyotrophic lateral sclerosis. Current Opinion in Neurology 34:5, pages 773-780.
Crossref
Ryutaro Nakamura, Mika Kurihara, Nobuhiro Ogawa, Akihiro Kitamura, Isamu Yamakawa, Shigeki Bamba, Mitsuru Sanada, Masaya Sasaki & Makoto Urushitani. (2021) Prognostic prediction by hypermetabolism varies depending on the nutritional status in early amyotrophic lateral sclerosis. Scientific Reports 11:1.
Crossref
Tanya S. McDonald, Vinod Kumar, Jenny N. Fung, Trent M. Woodruff & John D. Lee. (2021) Glucose clearance and uptake is increased in the SOD1 G93A mouse model of amyotrophic lateral sclerosis through an insulin‐independent mechanism . The FASEB Journal 35:7.
Crossref
Emanuele D’Amico, Giuseppe Grosso, Jeri W. Nieves, Aurora Zanghì, Pam Factor-Litvak & Hiroshi Mitsumoto. (2021) Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis. Nutrients 13:7, pages 2273.
Crossref
Estela Area-Gomez, D. Larrea, T. Yun, Y. Xu, J. Hupf, F. Zandkarimi, R. B. Chan & H. Mitsumoto. (2021) Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders. Scientific Reports 11:1.
Crossref
Elena Obrador, Rosario Salvador-Palmer, Rafael López-Blanch, Ali Jihad-Jebbar, Soraya L. Vallés & José M. Estrela. (2021) The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS. International Journal of Molecular Sciences 22:12, pages 6352.
Crossref
Laura Ferri, Paola Ajdinaj, Marianna Gabriella Rispoli, Claudia Carrarini, Filomena Barbone, Damiano D’Ardes, Margherita Capasso, Antonio Di Muzio, Francesco Cipollone, Marco Onofrj & Laura Bonanni. (2021) Diabetes Mellitus and Amyotrophic Lateral Sclerosis: A Systematic Review. Biomolecules 11:6, pages 867.
Crossref
Cyril Quessada, Alexandra Bouscary, Frédérique René, Cristiana Valle, Alberto Ferri, Shyuan T. Ngo & Jean-Philippe Loeffler. (2021) Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?. Cells 10:6, pages 1449.
Crossref
Shahram Oveisgharan, Ana W. CapuanoSukriti NagSonal AgrawalLisa L. BarnesDavid A. BennettZoe ArvanitakisJulie A. Schneider. (2021) Association of Hemoglobin A1C With TDP-43 Pathology in Community-Based Elders. Neurology 96:22.
Crossref
Marc-Olivier Deguise, Lucia Chehade & Rashmi Kothary. (2021) Metabolic Dysfunction in Spinal Muscular Atrophy. International Journal of Molecular Sciences 22:11, pages 5913.
Crossref
Colin J. Mahoney, Rebekah M. Ahmed, William Huynh, Sicong Tu, Jonathan D. Rohrer, Richard S. Bedlack, Orla Hardiman & Matthew C. Kiernan. (2021) Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis. CNS Drugs 35:5, pages 483-505.
Crossref
Jose Enrique de la Rubia Ortí, Jose Luis Platero Armero, Claudia Emmanuela Sanchis-Sanchis, Sandra Sancho-Castillo, Alejandro Salazar, Jordi Caplliure-Llopis, Esther Navarro-Illana, Carlos Barrios, Jesús Escribá-Alepuz & María Benlloch. (2021) Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose?. Journal of Clinical Medicine 10:8, pages 1582.
Crossref
Aksu Gunay, Heather H. Shin, Oge Gozutok, Mukesh Gautam & P. Hande Ozdinler. (2021) Importance of lipids for upper motor neuron health and disease. Seminars in Cell & Developmental Biology 112, pages 92-104.
Crossref
Alexandra Bouscary, Cyril Quessada, Frédérique René, Michael Spedding, Bradley J. Turner, Alexandre Henriques, Shyuan T. Ngo & Jean-Philippe Loeffler. (2021) Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Seminars in Cell & Developmental Biology 112, pages 82-91.
Crossref
T.J. Tracey, S.E. Kirk, F.J. Steyn & S.T. Ngo. (2021) The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis. Seminars in Cell & Developmental Biology 112, pages 69-81.
Crossref
Raquel Manzano, Janne Markus Toivonen, Laura Moreno‐Martínez, Miriam Torre, Leticia Moreno‐García, Tresa López‐Royo, Nora Molina, Pilar Zaragoza, Ana Cristina Calvo & Rosario Osta. (2020) What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy. British Journal of Pharmacology 178:6, pages 1279-1297.
Crossref
Kelby M. Killoy, Mariana Pehar, Benjamin A. Harlan & Marcelo R. Vargas. (2021) Altered expression of clock and clock‐controlled genes in a hSOD1‐linked amyotrophic lateral sclerosis mouse model. The FASEB Journal 35:2.
Crossref
Sophie Layalle, Laetitia They, Sarah Ourghani, Cédric Raoul & Laurent Soustelle. (2021) Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster. International Journal of Molecular Sciences 22:2, pages 904.
Crossref
Yangfan Cheng, Yongping Chen & Huifang Shang. (2021) Aberrations of biochemical indicators in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Translational Neurodegeneration 10:1.
Crossref
IsaacG Onyango, JamesP Bennett & GorazdB Stokin. (2021) Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases. Neural Regeneration Research 16:8, pages 1467.
Crossref
Anu Mary Varghese, Mausam Ghosh, Savita Kumari Bhagat, K. Vijayalakshmi, Veeramani Preethish-Kumar, Seena Vengalil, Pradeep-Chandra-Reddy Chevula, Saraswati Nashi, Kiran Polavarapu, Meenakshi Sharma, Rupinder Singh Dhaliwal, Mariamma Philip, Atchayaram Nalini, Phalguni Anand Alladi, Talakad N. Sathyaprabha & Trichur R. Raju. (2020) Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation. Journal of Neuroinflammation 17:1.
Crossref
Jiao Liu, Xiaoyue Luo, Xueping Chen & Huifang Shang. (2020) Lipid Profile in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Frontiers in Neurology 11.
Crossref
Francesco Gentile, Pietro Emiliano Doneddu, Nilo Riva, Eduardo Nobile-Orazio & Angelo Quattrini. (2020) Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration. International Journal of Molecular Sciences 21:20, pages 7471.
Crossref
Alexandra Bouscary, Cyril Quessada, Frédérique René, Michael Spedding, Alexandre Henriques, Shyuan Ngo & Jean-Philippe Loeffler. (2020) Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases. European Journal of Pharmacology 884, pages 173446.
Crossref
Michael Sloth Trabjerg, Anne Skøttrup Mørkholt, Jacek Lichota, Michal Krystian Egelund Oklinski, Dennis Christian Andersen, Katrine Jønsson, Kasper Mørk, Marie-Louise Nibelius Skjønnemand, Lona John Kroese, Colin Eliot Jason Pritchard, Ivo Johan Huijbers, Parisa Gazerani, Angelique Corthals & John Dirk Vestergaard Nieland. (2020) Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models. Scientific Reports 10:1.
Crossref
J. Schumacher, R. S. Peter, G. Nagel, D. Rothenbacher, A. Rosenbohm, A. C. Ludolph & J. Dorst. (2020) Statins, diabetes mellitus and prognosis of amyotrophic lateral sclerosis: data from 501 patients of a population‐based registry in southwest Germany. European Journal of Neurology 27:8, pages 1405-1414.
Crossref
Tiziana Petrozziello, Alexandra N. Mills, Sali M.K. Farhan, Kaly A. Mueller, Eric J. Granucci, Kelly E. Glajch, James Chan, Sheena Chew, James D. Berry & Ghazaleh Sadri‐Vakili. (2020) Lipocalin‐2 is increased in amyotrophic lateral sclerosis. Muscle & Nerve 62:2, pages 272-283.
Crossref
C. Carlomagno, P. I. Banfi, A. Gualerzi, S. Picciolini, E. Volpato, M. Meloni, A. Lax, E. Colombo, N. Ticozzi, F. Verde, V. Silani & M. Bedoni. (2020) Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis. Scientific Reports 10:1.
Crossref
D. Mariosa, F. Kamel, R. Bellocco, L.‐O. Ronnevi, C. Almqvist, H. Larsson, W. Ye & F. Fang. (2020) Antidiabetics, statins and the risk of amyotrophic lateral sclerosis. European Journal of Neurology 27:6, pages 1010-1016.
Crossref
Linjing Zhang, Lu Tang, Tao Huang & Dongsheng Fan. (2020) Life Course Adiposity and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study. Annals of Neurology 87:3, pages 434-441.
Crossref
Yiwei Wang, Aarti Mishra & Roberta Diaz Brinton. (2020) Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases. F1000Research 9, pages 68.
Crossref
Mara-Luciana Floare & Scott P. Allen. (2020) Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis. Neuroscience Insights 15, pages 263310552095730.
Crossref
Cristian A. Droppelmann, Danae Campos-Melo, Alexander J. Moszczynski, Hind Amzil & Michael J. Strong. (2019) TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS. Scientific Reports 9:1.
Crossref
Yue ShiKyoung Sun ParkSeung Hyun KimJia YuKaixuan ZhaoLina YuKi Wook OhKayoung LeeJaeyoon KimKanchan ChaggarYuxin LiAnnette C. Dolphin, William A. CatterallSung Ho RyuShao-Nian YangPer-Olof Berggren. (2019) IgGs from patients with amyotrophic lateral sclerosis and diabetes target Ca V α 2 δ1 subunits impairing islet cell function and survival . Proceedings of the National Academy of Sciences 116:52, pages 26816-26822.
Crossref
Di Zhang, Mingzhu Ma & Yueze Liu. (2019) Protective Effects of Incretin Against Age-Related Diseases. Current Drug Delivery 16:9, pages 793-806.
Crossref
Ping Zeng, Ting Wang, Junnian Zheng & Xiang Zhou. (2019) Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics. BMC Medicine 17:1.
Crossref
Scott P Allen, Benjamin Hall, Ryan Woof, Laura Francis, Noemi Gatto, Allan C Shaw, Monika Myszczynska, Jordan Hemingway, Ian Coldicott, Amelia Willcock, Lucy Job, Rachel M Hughes, Camilla Boschian, Nadhim Bayatti, Paul R Heath, Oliver Bandmann, Heather Mortiboys, Laura Ferraiuolo & Pamela J Shaw. (2019) C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis. Brain 142:12, pages 3771-3790.
Crossref
Ava Nasrolahi, Javad Mahmoudi, Ali Noori-Zadeh, Karimeh Haghani, Salar Bakhtiyari & Shahram Darabi. (2019) Shared Pathological Mechanisms Between Diabetes Mellitus and Neurodegenerative Diseases. Current Pharmacology Reports 5:4, pages 219-231.
Crossref
Kunihiko Araki, Amane Araki, Daiyu Honda, Takako Izumoto, Atsushi Hashizume, Yasuhiro Hijikata, Shinichiro Yamada, Yohei Iguchi, Akitoshi Hara, Kazuhiro Ikumi, Kaori Kawai, Shinsuke Ishigaki, Yoko Nakamichi, Shin Tsunekawa, Yusuke Seino, Akiko Yamamoto, Yasunori Takayama, Shihomi Hidaka, Makoto Tominaga, Mica Ohara-Imaizumi, Atsushi Suzuki, Hiroshi Ishiguro, Atsushi Enomoto, Mari Yoshida, Hiroshi Arima, Shin-ichi Muramatsu, Gen Sobue & Masahisa Katsuno. (2019) TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets. Journal of Clinical Investigation 129:9, pages 3578-3593.
Crossref
Johannes Dorst, Lu Chen, Angela Rosenbohm, Jens Dreyhaupt, Annemarie Hübers, Joachim Schuster, Jochen H. Weishaupt, Jan Kassubek, Burkhard Gess, Thomas Meyer, Ute Weyen, Andreas Hermann, Jürgen Winkler, Torsten Grehl, Tim Hagenacker, Paul Lingor, Jan C. Koch, Anne Sperfeld, Susanne Petri, Julian Großkreutz, Moritz Metelmann, Joachim Wolf, Andrea S. Winkler, Thomas Klopstock, Matthias Boentert, Siw Johannesen, Alexander Storch, Bertold Schrank, Daniel Zeller, Xiao-lu Liu, Lu Tang, Dong-Sheng Fan & Albert C. Ludolph. (2019) Prognostic factors in ALS: a comparison between Germany and China. Journal of Neurology 266:6, pages 1516-1525.
Crossref
Blanca I. Aldana. (2019) Microglia-Specific Metabolic Changes in Neurodegeneration. Journal of Molecular Biology 431:9, pages 1830-1842.
Crossref
Siobhan E. Kirk, Timothy J. Tracey, Frederik J. Steyn & Shyuan T. Ngo. (2019) Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 10.
Crossref
Sonja Korner, Johanna Kammeyer, Antonia Zapf, Magdalena Kuzma-Kozakiewicz, Maria Piotrkiewicz, Bożenna Kuraszkiewicz, Hanna Goszczynska, Marta Gromicho, Julian Grosskreutz, Peter M. Andersen, Mamede de Carvalho & Susanne Petri. (2019) Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS Population. Aging and disease 10:2, pages 205.
Crossref
Ernesto Manzo, Abigail G. O'Conner, Jordan M. Barrows, Dakotah D. Shreiner, Gabriel J. Birchak & Daniela C. Zarnescu. (2018) Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43. Frontiers in Molecular Neuroscience 11.
Crossref
Yuki Nakayama, Toshio Shimizu, Chiharu Matsuda, Michiko Haraguchi, Kentaro Hayashi, Yoko Mochizuki, Masahiro Nagao, Akihiro Kawata & Eiji Isozaki. (2018) Non-motor manifestations in ALS patients with tracheostomy and invasive ventilation. Muscle & Nerve 57:5, pages 735-741.
Crossref
P Kotnik, E Knapič, J Kokošar, J Kovač, R Jerala, T Battelino & S Horvat. (2017) Identification of novel alleles associated with insulin resistance in childhood obesity using pooled-DNA genome-wide association study approach. International Journal of Obesity 42:4, pages 686-695.
Crossref
Tijs Vandoorne, Katrien De Bock & Ludo Van Den Bosch. (2018) Energy metabolism in ALS: an underappreciated opportunity?. Acta Neuropathologica 135:4, pages 489-509.
Crossref
Timothy J. Tracey, Frederik J. Steyn, Ernst J. Wolvetang & Shyuan T. Ngo. (2018) Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease. Frontiers in Molecular Neuroscience 11.
Crossref
Pauline Vercruysse, Didier Vieau, David Blum, Åsa Petersén & Luc Dupuis. (2018) Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. Frontiers in Molecular Neuroscience 11.
Crossref
F. D'Ovidio, A. d'Errico, P. Carnà, A. Calvo, G. Costa & A. Chiò. (2018) The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis. European Journal of Neurology 25:1, pages 164-170.
Crossref
Qian-Qian Wei, Yongping Chen, Bei Cao, Ru Wei Ou, Lingyu Zhang, Yanbing Hou, Xiang Gao & Huifang Shang. (2017) Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival. Molecular Neurodegeneration 12:1.
Crossref
Héctor R. Martínez, César E. Escamilla-Ocañas, Carlos R. Camara-Lemarroy, María T. González-Garza, Juan M. Tenorio-Pedraza & Martín Hernández-Torre. (2017) CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis. Acta Neurologica Belgica 117:4, pages 879-883.
Crossref
Céline Desseille, Séverine Deforges, Olivier Biondi, Léo Houdebine, Domenico D’amico, Antonin Lamazière, Cédric Caradeuc, Gildas Bertho, Gaëlle Bruneteau, Laure Weill, Jean Bastin, Fatima Djouadi, François Salachas, Philippe Lopes, Christophe Chanoine, Charbel Massaad & Frédéric Charbonnier. (2017) Specific Physical Exercise Improves Energetic Metabolism in the Skeletal Muscle of Amyotrophic-Lateral- Sclerosis Mice. Frontiers in Molecular Neuroscience 10.
Crossref
Shachee Doshi, Preetika Gupta & Robert G. Kalb. (2017) Genetic induction of hypometabolism by ablation of MC4R does not suppress ALS-like phenotypes in the G93A mutant SOD1 mouse model. Scientific Reports 7:1.
Crossref
Simonetta Camandola & Mark P Mattson. (2017) Brain metabolism in health, aging, and neurodegeneration. The EMBO Journal 36:11, pages 1474-1492.
Crossref
Archi Joardar, Ernesto Manzo & Daniela C. Zarnescu. (2017) Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities. Current Genetic Medicine Reports 5:2, pages 108-114.
Crossref
Daniela Mariosa, Niklas Hammar, Håkan Malmström, Caroline Ingre, Ingmar Jungner, Weimin Ye, Fang Fang & Göran Walldius. (2017) Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Annals of Neurology 81:5, pages 718-728.
Crossref
Alberto Ferri & Roberto Coccurello. (2017) What is “Hyper” in the ALS Hypermetabolism?. Mediators of Inflammation 2017, pages 1-11.
Crossref
Yanwei Li, Lin Li & Christian Hölscher. (2016) Incretin-based therapy for type 2 diabetes mellitus is promising for treating neurodegenerative diseases. Reviews in the Neurosciences 27:7, pages 689-711.
Crossref
Mónica Zufiría, Francisco Javier Gil-Bea, Roberto Fernández-Torrón, Juan José Poza, Jose Luis Muñoz-Blanco, Ricard Rojas-García, Javier Riancho & Adolfo López de Munain. (2016) ALS: A bucket of genes, environment, metabolism and unknown ingredients. Progress in Neurobiology 142, pages 104-129.
Crossref
Pauline Vercruysse, Jérôme Sinniger, Hajer El Oussini, Jelena Scekic-Zahirovic, Stéphane Dieterlé, Reinhard Dengler, Thomas Meyer, Stephan Zierz, Jan Kassubek, Wilhelm Fischer, Jens Dreyhaupt, Torsten Grehl, Andreas Hermann, Julian Grosskreutz, Anke Witting, Ludo Van Den Bosch, Odile Spreux-Varoquaux, Albert C. Ludolph & Luc Dupuis. (2016) Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain 139:4, pages 1106-1122.
Crossref
Nirma D. Perera & Bradley J. Turner. (2015) AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis. Neurochemical Research 41:3, pages 544-553.
Crossref
Zara A. Ioannides, Shyuan T. Ngo, Robert D. Henderson, Pamela A. McCombe & Frederik J. Steyn. (2016) Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression. Neurodegenerative Diseases 16:5-6, pages 382-397.
Crossref
Anna Wuolikainen, Pär Jonsson, Maria Ahnlund, Henrik Antti, Stefan L. Marklund, Thomas Moritz, Lars Forsgren, Peter M. Andersen & Miles Trupp. (2016) Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects. Molecular BioSystems 12:4, pages 1287-1298.
Crossref
D. Mariosa, F. Kamel, R. Bellocco, W. Ye & F. Fang. (2015) Association between diabetes and amyotrophic lateral sclerosis in Sweden. European Journal of Neurology 22:11, pages 1436-1442.
Crossref
S.T. Ngo, F.J. Steyn, L. Huang, S. Mantovani, C.M.M. Pfluger, T.M. Woodruff, J.D. O'Sullivan, R.D. Henderson & P.A. McCombe. (2015) Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences 357:1-2, pages 22-27.
Crossref
Lavinia Palamiuc, Anna Schlagowski, Shyuan T Ngo, Aurelia Vernay, Sylvie Dirrig‐Grosch, Alexandre Henriques, Anne‐Laurence Boutillier, Joffrey Zoll, Andoni Echaniz‐Laguna, Jean‐Philippe Loeffler & Frédérique René. (2015) A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Molecular Medicine 7:5, pages 526-546.
Crossref
Rohini Raman, Scott P Allen, Emily F Goodall, Shelley Kramer, Lize-Linde Ponger, Paul R. Heath, Marta Milo, Hannah C. Hollinger, Theresa Walsh, J Robin Highley, Simon Olpin, Christopher J. McDermott, Pamela J. Shaw & Janine Kirby. (2015) Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathology and Applied Neurobiology 41:2, pages 201-226.
Crossref
Yu Sun, Chien-Jung Lu, Rong-Chi Chen, Wen-Hsuan Hou & Chung-Yi Li. (2015) Risk of Amyotrophic Lateral Sclerosis in Patients With Diabetes: A Nationwide Population-Based Cohort Study. Journal of Epidemiology 25:6, pages 445-451.
Crossref
Bhavin Parekh. (2015) A(a)LS: Ammonia-induced amyotrophic lateral sclerosis. F1000Research 4, pages 119.
Crossref
S.T. Ngo & F.J. Steyn. (2015) The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis. Cell Regeneration 4:1, pages 4:5.
Crossref
Tao Wang, Xin Jiang, Gang Chen & Jin Xu. (2015) Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration–associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways. Neurobiology of Aging 36:1, pages 527-535.
Crossref
Alain Lekoubou, Tandi E Matsha, Eugene Sobngwi & Andre P Kengne. (2014) Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review. BMC Research Notes 7:1.
Crossref
Rebekah M. AhmedMia MacMillanLauren BartleyGlenda M. HallidayMatthew C. KiernanJohn R. HodgesOlivier Piguet. (2014) Systemic metabolism in frontotemporal dementia. Neurology 83:20, pages 1812-1818.
Crossref
R. M. Ahmed, E. Mioshi, J. Caga, M. Shibata, M. Zoing, L. Bartley, O. Piguet, J. R. Hodges & M. C. Kiernan. (2014) Body mass index delineates ALS from FTD: implications for metabolic health. Journal of Neurology 261:9, pages 1774-1780.
Crossref
Soo-Jung Park, Ho-Hyun Jeong, Eun-Su Jang, Sang-Hyuk Kim, Sung-Chul Kim & Jong-Cheon Joo. (2014) Sasang Constitutional Characteristic of Amyotrophic Lateral Sclerosis. Journal of Sasang Constitutional Medicine 26:2, pages 156-164.
Crossref
Scott P. Allen, Sandeep Rajan, Lynn Duffy, Heather Mortiboys, Adrian Higginbottom, Andrew J. Grierson & Pamela J. Shaw. (2014) Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiology of Aging 35:6, pages 1499-1509.
Crossref
Susan E. Smittkamp, Jill K. Morris, Gregory L. Bomhoff, Mark E. Chertoff, Paige C. Geiger & John A. Stanford. (2014) SOD1-G93A Mice Exhibit Muscle-Fiber-Type-Specific Decreases in Glucose Uptake in the Absence of Whole-Body Changes in Metabolism. Neurodegenerative Diseases 13:1, pages 29-37.
Crossref
Pei-Yi Lin, Sharotka M Simon, Won Kyun Koh, Oluwarotimi Folorunso, C Samuel Umbaugh & Anson Pierce. (2013) Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis. Molecular Neurodegeneration 8:1.
Crossref
Nancy R. Stallings, Krishna Puttaparthi, Katherine J. Dowling, Christina M. Luther, Dennis K. Burns, Kathryn Davis & Jeffrey L. Elliott. (2013) TDP-43, an ALS Linked Protein, Regulates Fat Deposition and Glucose Homeostasis. PLoS ONE 8:8, pages e71793.
Crossref
Eva Lindauer, Luc Dupuis, Hans-Peter Müller, Heiko Neumann, Albert C. Ludolph & Jan Kassubek. (2013) Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS ONE 8:6, pages e67783.
Crossref
S. Körner, K. Kollewe, J. Ilsemann, A. Müller‐Heine, R. Dengler, K. Krampfl & S. Petri. (2012) Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. European Journal of Neurology 20:4, pages 647-654.
Crossref
Hui Sun, Sarah Knippenberg, Nadine Thau, Daniela Ragancokova, Sonja Körner, Dongya Huang, Reinhard Dengler, Klaus Döhler & Susanne Petri. (2012) Therapeutic Potential of N-Acetyl-Glucagon-Like Peptide-1 in Primary Motor Neuron Cultures Derived From Non-Transgenic and SOD1-G93A ALS Mice. Cellular and Molecular Neurobiology 33:3, pages 347-357.
Crossref
Wei Zhao, Merina Varghese, Prashant Vempati, Anastasiya Dzhun, Alice Cheng, Jun Wang, Dale Lange, Amanda Bilski, Irene Faravelli & Giulio Maria Pasinetti. (2012) Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease. PLoS ONE 7:11, pages e49191.
Crossref
Arnaud Tauffenberger, Alexandra Vaccaro, Anais Aulas, Christine Vande Velde & J. Alex Parker. (2012) Glucose delays age‐dependent proteotoxicity. Aging Cell 11:5, pages 856-866.
Crossref
Maurizio Muscaritoli, Irma Kushta, Alessio Molfino, Maurizio Inghilleri, Mario Sabatelli & Filippo Rossi Fanelli. (2012) Nutritional and metabolic support in patients with amyotrophic lateral sclerosis. Nutrition 28:10, pages 959-966.
Crossref
Guillaume Lehéricey, Nadine Le Forestier, Luc Dupuis, Jésus Gonzalez-Bermejo, Vincent Meininger & Pierre-François Pradat. (2012) Prise en charge nutritionnelle dans la sclérose latérale amyotrophique : un enjeu médical et éthique. La Presse Médicale 41:6, pages 560-574.
Crossref
Yazhou Li, Srinivasulu Chigurupati, Harold W. Holloway, Mohamed Mughal, David Tweedie, Daniel A. Bruestle, Mark P. Mattson, Yun Wang, Brandon K. Harvey, Balmiki Ray, Debomoy K. Lahiri & Nigel H. Greig. (2012) Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis. PLoS ONE 7:2, pages e32008.
Crossref
Dan Krakora, Corey Macrander & Masatoshi Suzuki. (2012) Neuromuscular Junction Protection for the Potential Treatment of Amyotrophic Lateral Sclerosis. Neurology Research International 2012, pages 1-8.
Crossref
Francesco Saccà, Mario Quarantelli, Carlo Rinaldi, Tecla Tucci, Raffaele Piro, Gaetano Perrotta, Barbara Carotenuto, Angela Marsili, Vincenzo Palma, Giuseppe Michele, Arturo Brunetti, Vincenzo Brescia Morra, Alessandro Filla & Marco Salvatore. (2011) A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. Journal of Neurology 259:1, pages 132-138.
Crossref
Wei Zhao, Merina Varghese, Shrishailam Yemul, Yong Pan, Alice Cheng, Paul Marano, Sadiq Hassan, Prashant Vempati, Fei Chen, Xianjuan Qian & Giulio M Pasinetti. (2011) Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Molecular Neurodegeneration 6:1.
Crossref
Jonathan A. Fidler, Christopher M. Treleaven, Ashley Frakes, Thomas J. Tamsett, Mary McCrate, Seng H. Cheng, Lamya S. Shihabuddin, Brian K. Kaspar & James C. Dodge. (2011) Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone. The FASEB Journal 25:12, pages 4369-4377.
Crossref
Luc Dupuis, Pierre-François Pradat, Albert C Ludolph & Jean-Philippe Loeffler. (2011) Energy metabolism in amyotrophic lateral sclerosis. The Lancet Neurology 10:1, pages 75-82.
Crossref
P.-F. Pradat, S. Attarian, J.-P. Camdessanché, L. Carluer, P. Cintas, P. Corcia, A. Echaniz-Laguna, J. Gonzalez-Bermejo, N. Guy, G. Nicolas, T. Perez, M.-H. Soriani, N. Vandenberghe & A. Verschueren. (2010) La recherche sur la SLA en 2009 : compte rendu du groupe bibliographique de la coordination des centres SLA. Revue Neurologique 166:8-9, pages 683-698.
Crossref
Annelies Quaegebeur & Peter Carmeliet. 2010. Diverse Effects of Hypoxia on Tumor Progression. Diverse Effects of Hypoxia on Tumor Progression 71 103 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.